Kindred Biosciences, Inc,a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of its initial public offering of 7,500,000 shares of its common stock at an initial public offering price of $7.00 per share for a total offering amount of $52,500,000 before deducting underwriting discounts and commissions and estimated offering expenses payable by Kindred Bio.
More News:
www.marketwired.com/press-release/kindred-bio-announces-pricing-of-initial-public-offering-1861618.htm
More News:
www.marketwired.com/press-release/kindred-bio-announces-pricing-of-initial-public-offering-1861618.htm
No comments:
Post a Comment